OasisLMS

“Liver diseases pose a significant public health burden worldwide. In recent years, artificial intelligence (AI) has been increasingly utilized in healthcare, including the field of liver diseases. AI has been applied for the diagnosis, risk stratification, and prognostic prediction of various liver conditions using clinical datasets and medical images. The Liver Cell Biology Special Interest Group (SIG) of the American Association for the Study of Liver Diseases (AASLD) has organized an engaging webinar to discuss the principles of AI and its applications in liver research and liver diseases. The main objectives of this webinar are as follows:

3. Use of AI for diagnosing and predicting disease progression in conditions such as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH), Hepatocellular Carcinoma (HCC), drug-induced liver injury, and other liver diseases.”